|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/115 | |
| A61P 35/00 | |||
| A61K 31/69 | |||
| A61K 31/7088 | |||
| A61K 31/7105 | |||
| A61K 31/713 | |||
| A61K 45/06 |
| (11) | Patento numeris | 2613789 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11757776.7 |
| Europos patento paraiškos padavimo data | 2011-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/004554 |
| Data | 2011-09-09 |
| (87) | Numeris | WO 2012/031773 |
| Data | 2012-03-15 |
| (30) | Numeris | Data | Šalis |
| 10009397 | 2010-09-09 | EP |
| (72) |
PURSCHKE, Werner, DE
JAROSCH, Florian, DE
EULBERG, Dirk, DE
KLUSSMANN, Sven, DE
BUCHNER, Klaus, DE
MAASCH, Christian, DE
DINSE, Nicole, DE
ZBORALSKI, Dirk, DE
|
| (73) |
Noxxon Pharma AG,
Max-Dohrn-Strasse 8-10, 10589 Berlin,
DE
|
| (54) | SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF IN CANCER TREATMENT |
| SDF-1 BINDING NUCLEIC ACIDS AND THE USE THEREOF IN CANCER TREATMENT |